|
Volumn 86, Issue 7, 2001, Pages 3327-3335
|
The sodium iodide symporter and its potential role in cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENTARY DNA;
GENE PRODUCT;
IODINE 125;
IODINE 131;
ISOTRETINOIN;
PROTEIN NIS;
RADIOACTIVE IODINE;
SODIUM IODIDE SYMPORTER;
UNCLASSIFIED DRUG;
CARRIER PROTEIN;
COTRANSPORTER;
MEMBRANE PROTEIN;
CANCER RADIOTHERAPY;
CANCER THERAPY;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
DNA LIBRARY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG UPTAKE;
GENE EXPRESSION;
GENE LOCATION;
GENE TARGETING;
GENE THERAPY;
GENETIC CODE;
HUMAN;
ION TRANSPORT;
MOLECULAR CLONING;
NONHUMAN;
PENDRED SYNDROME;
PRIORITY JOURNAL;
PROTEIN LOCALIZATION;
RADIATION DOSE;
REVIEW;
SODIUM TRANSPORT;
THYROID CANCER;
THYROID GLAND;
THYROID HORMONE SYNTHESIS;
TREATMENT OUTCOME;
ANIMAL;
BREAST TUMOR;
GENETICS;
METABOLISM;
NEOPLASM;
PHYSIOLOGY;
THYROID TUMOR;
UDDER;
ANIMALS;
BREAST NEOPLASMS;
CARRIER PROTEINS;
GENE EXPRESSION;
GENE THERAPY;
HUMANS;
MAMMARY GLANDS, ANIMAL;
MEMBRANE PROTEINS;
NEOPLASMS;
SYMPORTERS;
THYROID GLAND;
THYROID NEOPLASMS;
|
EID: 85047684770
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jcem.86.7.7641 Document Type: Review |
Times cited : (132)
|
References (59)
|